Search research articles
Contact Us
Filters
Showing results (71-80 of 159) with videos related to
Page
of 16
Sort By:
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
June 15, 2012
Phase II activity of belinostat (PXD-101), carboplatin, and paclitaxel in women with previously treated ovarian cancer
Don S Dizon, Lars Damstrup, Neil J Finkler, et al.
Cancer Biology & Therapy
|
February 19, 2011
Biomarkers in tissue from patients with upper gastrointestinal cancers treated with erlotinib and bevacizumab
Kristoffer Staal Rohrberg, Helle Pappot, Ulrik Lassen, et al.
Cancer Chemotherapy and Pharmacology
|
November 5, 2017
A drug-drug interaction study to assess the effect of the CYP1A2 inhibitor fluvoxamine on the pharmacokinetics of dovitinib (TKI258) in patients with advanced solid tumors
Vincent A de Weger, Sanjay Goel, Roger von Moos, et al.
JCO Precision Oncology
|
September 19, 2025
Clinical Benefit From Molecularly Guided Cancer Care: A Matching-Adjusted Indirect Comparison of Larotrectinib Versus Standard of Care
Carsten Bokemeyer, Keith R Abrams, Jesus Garcia-Foncillas, et al.
British Journal of Cancer
|
June 13, 2019
Plasma total cell-free DNA is a prognostic biomarker of overall survival in metastatic solid tumour patients
Ida Viller Tuxen, Lise Barlebo Ahlborn, Morten Mau-Soerensen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 3, 2015
Urokinase-Type Plasminogen Activator Receptor as a Potential PET Biomarker in Glioblastoma
Morten Persson, Mette K Nedergaard, Malene Brandt-Larsen, et al.
Neuro-Oncology
|
May 2, 2024
Immunotherapy drives mesenchymal tumor cell state shift and TME immune response in glioblastoma patients
Josephine D Hendriksen, Alessio Locallo, Simone Maarup, et al.
Cancer Investigation
|
February 3, 2018
Biomarkers in Recurrent Grade III Glioma Patients Treated with Bevacizumab and Irinotecan
Anders Toft, Thomas Urup, Ib Jarle Christensen, et al.
BMC Cancer
|
April 14, 2026
SENIPERA Phase 0/1 randomized window-of-opportunity clinical trial of SENIcapoc and PERAmpanel mono- and combination therapy of newly diagnosed glioblastoma: a trial protocol
Jens Toft Eschen, Line Louise Jensen, David Hausmann, et al.
Lung Cancer (Amsterdam, Netherlands)
|
March 21, 2023
New pathogenic germline variants identified in mesothelioma
Laila Belcaid, Birgitte Bertelsen, Karin Wadt, et al.
Page
of 16
Search research articles
Search
Showing results (71-80 of 159) with videos related to
Sort By:
Page
of 16
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
June 15, 2012
Phase II activity of belinostat (PXD-101), carboplatin, and paclitaxel in women with previously treated ovarian cancer
Don S Dizon, Lars Damstrup, Neil J Finkler, et al.
Cancer Biology & Therapy
|
February 19, 2011
Biomarkers in tissue from patients with upper gastrointestinal cancers treated with erlotinib and bevacizumab
Kristoffer Staal Rohrberg, Helle Pappot, Ulrik Lassen, et al.
Cancer Chemotherapy and Pharmacology
|
November 5, 2017
A drug-drug interaction study to assess the effect of the CYP1A2 inhibitor fluvoxamine on the pharmacokinetics of dovitinib (TKI258) in patients with advanced solid tumors
Vincent A de Weger, Sanjay Goel, Roger von Moos, et al.
JCO Precision Oncology
|
September 19, 2025
Clinical Benefit From Molecularly Guided Cancer Care: A Matching-Adjusted Indirect Comparison of Larotrectinib Versus Standard of Care
Carsten Bokemeyer, Keith R Abrams, Jesus Garcia-Foncillas, et al.
British Journal of Cancer
|
June 13, 2019
Plasma total cell-free DNA is a prognostic biomarker of overall survival in metastatic solid tumour patients
Ida Viller Tuxen, Lise Barlebo Ahlborn, Morten Mau-Soerensen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 3, 2015
Urokinase-Type Plasminogen Activator Receptor as a Potential PET Biomarker in Glioblastoma
Morten Persson, Mette K Nedergaard, Malene Brandt-Larsen, et al.
Neuro-Oncology
|
May 2, 2024
Immunotherapy drives mesenchymal tumor cell state shift and TME immune response in glioblastoma patients
Josephine D Hendriksen, Alessio Locallo, Simone Maarup, et al.
Cancer Investigation
|
February 3, 2018
Biomarkers in Recurrent Grade III Glioma Patients Treated with Bevacizumab and Irinotecan
Anders Toft, Thomas Urup, Ib Jarle Christensen, et al.
BMC Cancer
|
April 14, 2026
SENIPERA Phase 0/1 randomized window-of-opportunity clinical trial of SENIcapoc and PERAmpanel mono- and combination therapy of newly diagnosed glioblastoma: a trial protocol
Jens Toft Eschen, Line Louise Jensen, David Hausmann, et al.
Lung Cancer (Amsterdam, Netherlands)
|
March 21, 2023
New pathogenic germline variants identified in mesothelioma
Laila Belcaid, Birgitte Bertelsen, Karin Wadt, et al.
Page
of 16